Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US8476010 | FRESENIUS KABI USA | Propofol formulations with non-reactive container closures |
Dec, 2024
(7 months from now) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5714520 | FRESENIUS KABI USA | Propofol compostion containing edetate |
Mar, 2015
(9 years ago) | |
US5731355 | FRESENIUS KABI USA | Pharmaceutical compositions of propofol and edetate |
Mar, 2015
(9 years ago) | |
US5731356 | FRESENIUS KABI USA | Pharmaceutical compositions of propofol and edetate |
Mar, 2015
(9 years ago) | |
US5908869 | FRESENIUS KABI USA | Propofol compositions containing edetate |
Mar, 2015
(9 years ago) | |
US5714520 (Pediatric) | FRESENIUS KABI USA | Propofol compostion containing edetate |
Sep, 2015
(8 years ago) | |
US5731355 (Pediatric) | FRESENIUS KABI USA | Pharmaceutical compositions of propofol and edetate |
Sep, 2015
(8 years ago) | |
US5731356 (Pediatric) | FRESENIUS KABI USA | Pharmaceutical compositions of propofol and edetate |
Sep, 2015
(8 years ago) | |
US5908869 (Pediatric) | FRESENIUS KABI USA | Propofol compositions containing edetate |
Sep, 2015
(8 years ago) | |
US8476010 (Pediatric) | FRESENIUS KABI USA | Propofol formulations with non-reactive container closures |
Jun, 2025
(1 year, 1 month from now) |
Market Authorisation Date: 02 October, 1989
Treatment: Method of producing anesthesia; Method for limiting the potential for microbial growth in the drug product; Method of improving the time for administration or the time between changes of giving sets f...
Dosage: INJECTABLE;INJECTION